申请人:CANCER REC TECH LTD
公开号:WO2016124938A1
公开(公告)日:2016-08-11
The present invention relates to compounds of formula (I): wherein R1, R2, R3, R4a, R4b, R4C, R4d, L, A, Q, W and HET are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions (e.g. fibrosis) in which ATX activity is implicated.
本发明涉及如下式(I)的化合物:其中R1、R2、R3、R4a、R4b、R4C、R4d、L、A、Q、W和HET分别如本文所定义。本发明的化合物是自体脂肪酶(ATX)酶活性的抑制剂。本发明还涉及制备这些化合物的方法,包括含有它们的药物组合物,以及它们在治疗增殖性疾病(如癌症)以及ATX活性有所涉及的其他疾病或情况(如纤维化)中的用途。